Amarin Corp Plc (AMRN)

[TCI1]

Can anyone give an opinion as to what the effect positive Brave results will have on the share price/co valuation? Most posters believe it will be significant. While I hope so too, Evaporate - confirming Vascepa as a liquid stent - didn’t have any impact at all. The Brave study is small & I just don’t see the FDA approving it for any AD indication. If another larger study is required then Brave would be of limited value. Also, off label scripts may rise but generics will take 40%, in the US anyway & there is zero promotion. Could Brave have an impact in EU? I’d like to hear what people think and their rationale.

Slightly sidetracking but the way Ozempic was touted as reducing heart attack and stroke by 20% as if this was exceptional is a sad indictment of the management of Vascepa. I’m convinced PCPs and a large number of Cardiologists aren’t even aware the 25% reduction in MACE is on top of statins. Boggles the mind that such a great, relatively inexpensive drug has so little traction and awareness.